Biomedical research is a costly process

As health care costs rise, speculation abounds about which industry is to blame. Is it insurance companies, or hospitals, or the pharmaceutical companies or the research institutes? Former Pennsylvania congressman Jim Greenwood explains that it costs millions of dollars to conduct research for new drugs. Greenwood, Chief Executive Officer of the Biotechnology Innovation Organization, talks about producing new medications, health care and the presidential campaign with host Dan Lovallo on Front & Center. #health care #medication #pharmaceuticals